ArticleInternational journal of women's health2026
Elevated Visceral Adiposity Index is Associated with Reproductive Endocrine Characteristics, and Adverse Pregnancy Outcomes in Chinese Women with Polycystic Ovary Syndrome.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the visceral adiposity index (VAI) as a metabolic and reproductive risk marker in Chinese women with polycystic ovary syndrome (PCOS). Methods: Secondary analysis of 956 women with PCOS from the PCOSAct trial. VAI was calculated from waist circumference, BMI, triglycerides, and HDL-C. Associations with anthropometric, metabolic, endocrine, and pregnancy outcomes were assessed using regression models. Predictive performance for insulin resistance (IR) and non-alcoholic fatty liver disease (NAFLD) was evaluated via ROC analysis. Results: Elevated VAI was positively associated with age, BMI, blood pressure, dysglycemia, dyslipidemia, FT, hepatic enzymes, and prevalence of IR, MetS, and NAFLD (all Conclusion: VAI is a practical, non-invasive tool for identifying metabolic dysfunction and predicting adverse pregnancy outcomes in women with PCOS, supporting its use for risk stratification and early intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.